RSS Feed

Latest news

New anticonvulsant brivaracetam launches

New anticonvulsant brivaracetam launches

Briviact (brivaracetam) is licensed as adjunctive therapy...

Guanfacine: new option in ADHD unresponsive to stimulants

Guanfacine: new option in ADHD unresponsive to stimulants

Guanfacine (Intuniv) is a once-daily treatment for...

Prescribe levonorgestrel-releasing IUS by brand, GPs advised

Prescribe levonorgestrel-releasing IUS by brand, GPs advised

Levonorgestrel-releasing intrauterine systems (IUS)...

Galantamine: reports of serious skin reactions

Galantamine: reports of serious skin reactions

Serious skin reactions have occurred in patients taking...

Analgesic inhaler launched for use in trauma patients

Analgesic inhaler launched for use in trauma patients

Trauma patients with moderate to severe pain can now...

New and deleted products

Promo Image

New Products

Products added to MIMS.

Promo Image

Deleted Products

Products removed from MIMS.

Latest CPD from MIMS Learning

Most popular

Switching and Withdrawing Antidepressants

Quick-reference guide to switching and withdrawing...


Bloating and Wind

Summary of Antibiotic Treatments in Adults

Dose regimens for common bacterial infections.

Hormone Replacement Therapy (HRT)

Comparison table containing key information on HRT...

Featured MIMS resources

Promo Image

Routine Childhood Immunisation Schedule

Quick-reference summary of the UK childhood vaccination programme.

Promo Image

Menopause: diagnosis and management (NICE Guideline)

At-a-glance summary of NICE guidance on menopause.

Patient fact sheets

Browse the MIMS patient fact sheet library and find printable patient information on topics from acne to yellow fever.






Contact details and drug listings for manufacturers in MIMS

New products coming soon to MIMS

Check back soon to find MIMS listings for the following new drugs:

Benepali (etanercept)

Cholib (fenofibrate/simvastatin)

Elocta (efmoroctocog alfa)

Farydak (panobinostat)

Fertavid (follitropin beta)

Imlygic (talimogene laherparepvec)

Orkambi (lumacaftor/ivacaftor)

Zalviso (sufentanil)

Latest from MIMS Dermatology

1 CPD credit: Management of atopic eczema in children

Compliance is the key to effective therapy. By Dr Andre...

1 CPD credit: Urgent referrals in dermatology

An overview of conditions requiring urgent referral....

The importance of early diagnosis in Lyme disease

A thorough history and recognition of the erythema...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.

This site is intended for healthcare professionals.